We recently compiled a list of the 10 Hottest Mid-Cap Stocks So Far in 2025. In this article, we are going to take a look at where Inari Medical, Inc. (NASDAQ:NARI) stands against the other mid-cap ...

Stryker is now opening its pocketbook a bit wider to acquire Inari Medical with its portfolio of blood-clot-busting devices and 1,400 employees. Stryker will put down $80 per share in cash for ...

Learn more about whether Glaukos Corporation or Inari Medical, Inc. is a better investment based on AAII's A+ Investor grades ...

Inari Medical stock skyrocketed Monday afternoon and again Tuesday morning after a report that it was close to being acquired by Stryker proved to be true, with the companies announcing the deal after ...

Inari’s portfolio of medical devices and accessories to treat venous thromboembolism (VTE), or blood clots in the veins, was highly attractive to Stryker, according to Inari Chief Executive Drew Hykes ...

Investing.com -- Inari Medical Inc (NASDAQ ... a condition where blood clots form in veins, as well as other vascular diseases. Stryker will pay $80 per share for Inari, as initially reported ...

Inari Medical (NASDAQ:NARI) makes medical devices. These devices are mostly used to treat blot clots in veins. Inari Medical is what I discussed before in an article talking about mid-cap stocks.

Inari Medical Inc is a medical device company focused ... Its product portfolio includes; ClotTriever, for the removal of the clot from peripheral blood vessels and treats patients suffering ...

Inari Medical (NARI – Research Report ... Its product portfolio includes ClotTriever, for the removal of the clot from peripheral blood vessels and treats patients suffering from deep vein ...